This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tay, S. K. H. Articles by DiMauro, S. Search for Related Content PubMed PubMed Citation Articles by Tay, S. K. H. Articles by DiMauro, S. Pubmed/NCBI databases Genetics Home Reference Social Bookmarking                   What's this?

Clinical and Genetic Features in Two Families With MELAS and the T3271C Mutation in Mitochondrial DNA

Department of Neurology Columbia University College of Physicians and Surgeons, New York, NY

Sara Shanske, PhD

Department of Neurology Columbia University College of Physicians and Surgeons, New York, NY

Carol Crowe, MD

Metro Health Medical Center, Cleveland, OH

Alan Shanske, MD

Center for Congenital Disorders, Montefiore Medical Center, Bronx, NY

Irwin Schafer, MD

Metro Health Medical Center, Cleveland, OH

Jacklyn Pancrudo, MSc

Department of Neurology Columbia University College of Physicians and Surgeons, New York, NY

Jiesheng Lu, MD

Department of Neurology Columbia University College of Physicians and Surgeons, New York, NY

Eduardo Bonilla, MD

Department of Neurology Columbia University College of Physicians and Surgeons, New York, NY

Salvatore DiMauro, MD

Department of Neurology Columbia University College of Physicians and Surgeons, New York, NY, sd12{at}colombia.edu

The majority of patients with MELAS (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) have the A3243G point mutation. The much rarer T3271C mutation has been reported predominantly in Japanese subjects. Our objective was to better define the clinical phenotype and mutation load in patients with MELAS and the T3271C mutation in mitochondrial DNA. We present clinical and molecular genetic data in two pedigrees with the T3271C mutation. The age at onset was 8 years in one proband and 14 years in the other. Both patients had migrainelike headache, seizures, and strokelike episodes. Mutation loads were quantified in multiple tissues from the patients and from family members by polymerase chain reaction—restriction fragment length polymorphism analysis. The symptoms in both probands were typical of MELAS, and, contrary to previous reports, onset was early. Hearing loss was less common than in typical MELAS, and ragged red fibers were absent. The proportion of mutant genomes was consistently and markedly greater in DNA from urinary sediment than from blood. In the mother of one proband, mutant genomes were detected only in DNA from hair follicles and cheek mucosa. The phenotype of patients with the T3271C mutation might not be as distinct as that of the A3243G mutation, as previously described. Our data also suggest that urine is a better source of DNA than blood for diagnosis and that multiple tissues should be studied in maternal relatives, especially when the mutation cannot be detected in blood. (J Child Neurol 2005;20:142—146).

Journal of Child Neurology, Vol. 20, No. 2, 142-146 (2005)
DOI: 10.1177/08830738050200022301


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?